Announcements

RSS Feed

Showing items 791 - 800 of 948 stories.

Kristina Marinak recently elected to represent Early Career Ambassadors

Kristina Marinak, a graduate student in the lab of Dr. Elena Pugacheva, has been elected to represent the Early Career Ambassadors (ECAM) of the Metastasis Research Society (MRS), by serving on their Early Career Leadership Council (ECLC). As an elected member of the ECLC, she will work with the ECLC Chair and the MRS board of directors, to develop and implement ECAM-sponsored activities that advance the mission of the society as they work towards enhancing the quality and longevity of the lives of patients with metastatic cancer. The ECLC supports the MRS’s mission to: understand the process of metastasis at the cellular, molecular and biochemical levels; identify and evaluate therapeutics for their ability to control or reduce metastases in preclinical models; and work with clinical colleagues to design and implement clinical trials to translate findings to the clinic. This 4-year term will begin this year in September at the 16th Biennial MRS Congress in Chengdu, China, where she will be presenting her research as a poster presentation.  Kristina is currently researching the role of nuclear Aurora-A Kinase in promoting triple negative breast cancer metastasis.  Kristina is also a member of WVU's Graduate Student Organization. Congratulations Kristina!

ICRC Researcher on "Public Health Minute"

Dr. Kimberly Rauscher spoke on the radio segment "Public Health Minute". She discussed her research on prevention of work injuries among youth.  "Public Health Minute" is sponsored by the Lehman College school of Health Sciences, Human Services & Nursing and The City University of New York.  To access the recording click here: http://bit.ly/29kBky4 

Dr. Robert Pack to present on Prescription Drug Abuse

Dr. Robert Pack, Professor of Community and Behavioral Health, Associate Dean for Academic Affairs in the College of Public Health at East Tennessee State University, and Director of the new ETSU Center for Prescription Drug Abuse Prevention and Treatment will present on “Prescription Drug Abuse a Decade into the Epidemic: Lessons learned in Tennessee”.

James Simpkins wins national award for mentoring and research excellence

MORGANTOWN, W.Va. – Earlier today West Virginia clinical and Translational Science Institute pilot recipient and mentor James “Jim” Simpkins, Ph.D., was awarded the inaugural Clinical and Translational Research (CTR) Award at the National IDeA Symposium of Biomedical Research Excellence (NISBRE) in Washington D.C.

Learning and Clinical Integration Grants: Call for applications

The Learning and Clinical Integration Team at Genentech, a member of the Roche Group, has recently published three Call for Grant Notifications (CGNs) for independent, certified medical education in various disease areas. They are publicly available through Genentech's funding site, the Society for Academic Continuing Medical Education (SACME) site, and the Alliance for Continuing Education in Health Professions (ACEHP) site. More therapeutic areas or support may also be listed on the funding website.  To review the details of these requests, including criteria, due dates, and submission procedures, please go to the Genentech funding request website: funding.gene.com

REQUEST FOR GRANT PROPOSALS TO WVU ICRC

On behalf of the West Virginia University Injury Control Research Center’s (ICRC) Director, Dr. Robert Bossarte, and Principal Investigator, Dr. Jeffrey Coben, we are pleased to invite ICRC affiliated faculty to submit proposals for research projects to be conducted as part of ICRC-funded activities during the fiscal years 2018-2019.  If not an affiliate faculty, we encourage you to submit your idea, however if funded, you will agree to accept the terms and conditions of affiliation with our center.  Interested investigators should prepare a two- to three-page letter of intent describing the project’s objectives, setting, research team and projected cost. Based on current guidance from the Centers for Disease Control and Prevention, we anticipate support will be available for two to three R03- or R21-scale projects over the two-year period. Proposed projects may be one to two years in length with total annual cost between $50,000-$200,000. Proposed projects should address areas of ICRC activities, funded during the last five years (e.g., opioid/opiate overdose prevention, motor-vehicle-related deaths and injuries, falls among older persons, suicide prevention, intimate partner violence), be consistent with research priorities identified by the National Center for Injury Prevention and Control, and focus on implementation/translational science or the impact of policy change/implementation. Letters of intent should be submitted electronically to Mr. Dave Fulaytar (dfulaytar@hsc.wvu.edu) by June 30, 2016. Investigators of selected projects will be notified by July 8, 2016 and full proposals will be due by August 5, 2016. Guidance on formatting requirements for full proposals will be provided to selected investigators as it becomes available from the Centers for Disease Control and Prevention. Questions about proposed projects or ICRC priorities should be directed Dr. Robert Bossarte (rbossarte@hsc.wvu.edu) or the ICRC Deputy Director, Mr. Herbert Linn (hlinn2@hsc.wvu.edu).